BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28659656)

  • 21. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.
    Sharma D; Saxena NK; Vertino PM; Anania FA
    Endocr Relat Cancer; 2006 Jun; 13(2):629-40. PubMed ID: 16728588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma.
    Mhawech-Fauceglia P; Wang D; Kesterson J; Syriac S; Clark K; Frederick PJ; Lele S; Liu S
    PLoS One; 2011 Mar; 6(3):e18066. PubMed ID: 21448288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin-cytokine crosstalk in breast cancer.
    Newman G; Gonzalez-Perez RR
    Mol Cell Endocrinol; 2014 Jan; 382(1):570-582. PubMed ID: 23562747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium.
    Cao QJ; Belbin T; Socci N; Balan R; Prystowsky MB; Childs G; Jones JG
    Int J Gynecol Pathol; 2004 Oct; 23(4):321-9. PubMed ID: 15381901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.
    Ko EM; Walter P; Clark L; Jackson A; Franasiak J; Bolac C; Havrilesky L; Secord AA; Moore DT; Gehrig PA; Bae-Jump VL
    Gynecol Oncol; 2014 Apr; 133(1):28-32. PubMed ID: 24680588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers.
    Suzuki T; Aoki D; Susumu N; Udagawa Y; Nozawa S
    Int J Oncol; 2000 Dec; 17(6):1131-9. PubMed ID: 11078798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor-II mRNA-binding protein 3 immunocytochemical expression in direct endometrial brushings: Possible diagnostic help in endometrial cytology.
    Norimatsu Y; Yanoh K; Maeda Y; Irino S; Hirai Y; Fulciniti F; Kobayashi TK
    Cytopathology; 2019 Mar; 30(2):215-222. PubMed ID: 30614088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
    Liao YM; Song Y; Li YK; Du JH; Zhou Y
    Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
    Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
    J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
    Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
    Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Notch, IL-1 and leptin expression in colorectal cancer.
    Erkasap N; Ozyurt R; Ozkurt M; Erkasap S; Yasar F; Ihtiyar E; Ciftci E; Canaz F; Colak E
    Exp Ther Med; 2021 Jun; 21(6):600. PubMed ID: 33884038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
    Schultheis AM; Martelotto LG; De Filippo MR; Piscuglio S; Ng CK; Hussein YR; Reis-Filho JS; Soslow RA; Weigelt B
    Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p53 in imprint smears of endometrial carcinoma.
    Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.
    Xiao Z; He Y; Liu C; Xiang L; Yi J; Wang M; Shen T; Shen L; Xue Y; Shi H; Liu P
    Oncol Rep; 2019 May; 41(5):2667-2678. PubMed ID: 30896884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells.
    Mori M; Miyamoto T; Yakushiji H; Ohno S; Miyake Y; Sakaguchi T; Hattori M; Hongo A; Nakaizumi A; Ueda M; Ohno E
    Hum Cell; 2012 Mar; 25(1):9-15. PubMed ID: 22189483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.